Navigation Links
USDA Boosts Food Safety Research with Purchase of Waters ACQUITY TQD System

UPLC/Tandem Quadrupole Mass Spectrometry System Intended for Veterinary Drug Residue Analysis of Poultry and Livestock

MILFORD, Mass., Feb. 27 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) announced today that the United States Department of Agriculture's Agricultural Research Service has purchased a Waters(R) ACQUITY(R) TQD System to develop rapid and accurate test methods for screening poultry and beef for trace concentrations of veterinary drug residues. The instrument purchased is for the USDA's Wyndmoor, Pa. research laboratory.

Farm-raised poultry and livestock often receive drugs to protect them from disease and promote their growth. Through ignorance, carelessness or deceit on the part of a small number of producers, poultry and livestock that enter the food chain can contain banned substances or legal drugs at concentrations that exceed maximum allowable levels. The need to obtain more information from a single injection is underscored by increasing demands on laboratory time and resources for reproducible, highly-accurate and precise results on larger numbers of samples.

Analytical methods that employ UltraPerformance Liquid Chromatography (UPLC(R)) coupled with tandem mass spectrometry can screen for more than 100 different drug residues at a time at concentrations of less than 10 ng/mL, a big improvement in speed, efficiency, and sensitivity over the traditional seven-plate bioassay method.

The USDA chose Waters ACQUITY TQD System based on criteria for a UPLC/MS/MS system with a tandem quadrupole mass spectrometry detector capable of 20 millisecond positive and negative switching, a feature deemed highly-important for multi-analyte detection of both positively and negatively-charged compounds in a single analytical run.

Waters ACQUITY TQD System features the Waters ACQUITY UltraPerformance LC(R) System (UPLC(R)), a tandem quadrupole (TQ) mass detector, ACQUITY BEH analytical columns, all operated under Waters MassLynx(TM) 4.1 Mass Spectrometry Software. The MassLynx Software includes TargetLynx(TM) software for targeted analyte quantification and the QuanOptimise(TM) feature for automated system optimization and method development. This UPLC/MS/MS system operates with 1.7 micron ACQUITY BEH Columns and is a true UPLC system for measuring concentrations of veterinary drug residues, pesticides, and other contaminants in foods and beverages.

For More Information

More information on Waters ACQUITY TQD System, visit For more information on Waters entire portfolio of LC/MS/MS products, please visit:

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.58 billion in 2008 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, UltraPerformance LC, UPLC, ACQUITY, MassLynx, QuanOptimise, and TargetLynx are trademarks of Waters Corporation.

    Brian J. Murphy
    Waters Corporation
    Public Relations Manager

SOURCE Waters Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. KanekaQH(TM) Ubiquinol Dramatically Boosts Ejection Fraction in Patients With Late-Stage Congestive Heart Failure
2. Winning University of Melbourne Ph.D. research boosts the search for sensitive sensors
3. New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture
4. On the boil: New nano technique significantly boosts boiling efficiency
5. Genzyme Boosts Quality Using Dyadem Quality Lifecycle Management
6. Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections
7. New Scandinavian collaboration boosts nanotech development
8. Murad Boosts Skin Immunity With the New Murad(R) Professional Line
9. Hospira Advances Patient Safety With New GemStar(R) SP Infusion System
10. Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer
11. Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
(Date:11/24/2015)... SUNNYVALE, Calif. , Nov. 24, 2015 ... executives will be speaking at the following conference, and ... New York, NY      Tuesday, December 1, ... New York, NY      Tuesday, December 1, ...      Piper Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... Florida (PRWEB) , ... November 24, 2015 , ... ... biggest event of the year and one of the premier annual events for ... and ran from 8–11 November 2015, where ISPE hosted the largest number of ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... published a new market report titled  Gesture Recognition Market ... Forecast, 2015 - 2021. According to the report, the global gesture ... is anticipated to reach US$29.1 bn by 2021, at ... North America dominated the global ...
(Date:11/17/2015)... Nov. 17, 2015  Vigilant Solutions announces today that ... Board of Directors. --> ... retiring from the partnership at TPG Capital, one of ... over $140 Billion in revenue.  He founded and led ... the TPG companies, from 1997 to 2013.  In his ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
Breaking Biology News(10 mins):